Comparison of minocycline susceptibility testing methods for carbapenem-resistant acinetobacter baumannii

Journal of Clinical Microbiology

Volumn 54, Issue 12, 2016, Pages 2937-2941

  Wang, Peng ^a,b   Bowler, Sarah L ^a   Kantz, Serena F ^a   Mettus, Roberta T ^a   Guo, Yan ^a,c   McElheny, Christi L ^a   Doi, Yohei ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MINOCYCLINE; TIGECYCLINE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; FEASIBILITY STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; ACINETOBACTER INFECTIONS; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 84997707975     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01810-16     Document Type: Article

References (26)

1. Doi Y, Murray GL, Peleg AY. 2015. Acinetobacter baumannii: Evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med 36:85-98. http://dx.doi.org/10.1055/s-0034-1398388.
2. Flamm RK, Castanheira M, Streit JM, Jones RN. 2016. Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013). Diagn Microbiol Infect Dis 85:352- 355. http://dx.doi.org/10.1016/j.diagmicrobio.2016.03.019.
3. Lemos EV, de la Hoz FP, Einarson TR, McGhan WF, Quevedo E, Castaneda C, Kawai K. 2014. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: Systematic review and meta-analysis. Clin Microbiol Infect 20:416-423. http://dx.doi.org/10 .1111/1469-0691.12363.
4. Viehman JA, Nguyen MH, Doi Y. 2014. Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs 74:1315-1333. http://dx.doi.org/10.1007/s40265-014 -0267-8.
5. Ritchie DJ, Garavaglia-Wilson A. 2014. A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections. Clin Infect Dis 59(Suppl 6):S374-S380.
6. Liu JW, Ko WC, Huang CH, Liao CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Chen YH, Lu PL, Sun W, Wang LS, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR. 2012. Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: Results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010. Antimicrob Agents Chemother 56:1414 -1417. http://dx.doi.org/10.1128/AAC.05879-11.
7. Kulah C, Celebi G, Aktas E, Mengeloglu Z, Comert F, Ankarali H. 2009. Unexpected tigecycline resistance among Acinetobacter baumannii isolates: High minor error rate by Etest. J Chemother 21:390-395. http://dx .doi.org/10.1179/joc.2009.21.4.390.
8. Dimitriadis P, Protonotariou E, Varlamis S, Poulou A, Vasilaki O, Metallidis S, Tsakris A, Malisiovas N, Skoura L, Pournaras S. 2016. Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii. Int J Antimicrob Agents 48:321-323. http://dx.doi.org/10.1016/j.ijantimicag.2016.05.017.
9. Adams-Haduch JM, Onuoha EO, Bogdanovich T, Tian GB, Marschall J, Urban CM, Spellberg BJ, Rhee D, Halstead DC, Pasculle AW, Doi Y. 2011. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J Clin Microbiol 49:3849-3854. http://dx.doi.org/10.1128/JCM.00619-11.
10. Munoz-Price LS, Fajardo-Aquino Y, Arheart KL, Cleary T, DePascale D, Pizano L, Namias N, Rivera JI, O'Hara JA, Doi Y. 2013. Aerosolization of Acinetobacter baumannii in a trauma ICU. Crit Care Med 41:1915- 1918. http://dx.doi.org/10.1097/CCM.0b013e31828a39c0.
11. Munoz-Price LS, Namias N, Cleary T, Fajardo-Aquino Y, Depascale D, Arheart KL, Rivera JI, Doi Y. 2013. Acinetobacter baumannii: Association between environmental contamination of patient rooms and occupant status. Infect Control Hosp Epidemiol 34:517-520. http://dx.doi.org/10 .1086/670209.
12. Qureshi ZA, Hittle LE, O'Hara JA, Rivera JI, Syed A, Shields RK, Pasculle AW, Ernst RK, Doi Y. 2015. Colistin-resistant Acinetobacter baumannii: Beyond carbapenem resistance. Clin Infect Dis 60:1295-1303.
13. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial disk susceptibility tests; approved standard. CLSI document M02-A11. Clinical and Laboratory Standards Institute, Wayne, PA.
15. Clinical and Laboratory Standards Institute. 2016. Performance standard for antimicrobial susceptibility testing; 26th informational supplement. CLSI document M100-S26. Clinical and Laboratory Standards Institute, Wayne, PA.
16. Tan TY, Ng LS, Chen DM. 2010. Influence of different Mueller-Hinton agars and media age on Etest susceptibility testing of tigecycline. Diagn Microbiol Infect Dis 68:93-95. http://dx.doi.org/10.1016/j.diagmicrobio .2010.05.001.
17. Navon-Venezia S, Leavitt A, Carmeli Y. 2007. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 59:772-774. http://dx.doi.org/10.1093/jac/dkm018.
18. Bobenchik AM, Hindler JA, Giltner CL, Saeki S, Humphries RM. 2014. Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp. J Clin Microbiol 52:392-397. http://dx .doi.org/10.1128/JCM.02432-13.
19. Denys GA, Callister SM, Dowzicky MJ. 2013. Antimicrobial susceptibility among Gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.). Ann Clin Microbiol Antimicrob 12:24. http://dx.doi.org/10 .1186/1476-0711-12-24.
20. Zilberberg MD, Kollef MH, Shorr AF. 2016. Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study. J Hosp Med 11:21-26. http://dx.doi.org/10.1002/jhm.2477.
21. Barry AL, Reller LB, Miller GH, Washington JA, Schoenknect FD, Peterson LR, Hare RS, Knapp C. 1992. Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. J Clin Microbiol 30:585- 589.
22. McMurry LM, Aronson DA, Levy SB. 1983. Susceptible Escherichia coli cells can actively excrete tetracyclines. Antimicrob Agents Chemother 24: 544-551. http://dx.doi.org/10.1128/AAC.24.4.544.
23. Marchaim D, Pogue JM, Tzuman O, Hayakawa K, Lephart PR, Salimnia H, Painter T, Zervos MJ, Johnson LE, Perri MB, Hartman P, Thyagarajan RV, Major S, Goodell M, Fakih MG, Washer LL, Newton DW, Malani AN, Wholehan JM, Mody L, Kaye KS. 2014. Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method. J Clin Microbiol 52:1617-1621. http://dx.doi.org/10.1128/JCM.00001-14.
24. Fernandez-Mazarrasa C, Mazarrasa O, Calvo J, del Arco A, Martinez-Martinez L. 2009. High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest. J Clin Microbiol 47:827-829. http://dx.doi.org/10.1128/JCM.02464-08.
25. Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Sader HS. 2007. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 45:227-230. http: //dx.doi.org/10.1128/JCM.01588-06.
26. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. 2013. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41:11-19. http://dx.doi.org/10.1016/j.ijantimicag.2012 .09.008.